You are here

Home ›

In the News

“Pancreatic cancer drug-sensitivity predicted by synergy of PAWI-2 and protein biomarker expression”

Submitted by ChemRegen on Fri, 09/18/2020 - 10:24

Potent inhibitor of pancreatic cancer stem cells that synergizes current standard of care, PAWI-2 is featured in Investigational New Drugs.

Collaborators

The Human BioMolecular Research Institute

The Sanford-Burnham Medical Research Institute

Signup

Stay Informed. Join our mailing list to receive the latest news...